US.DXCM · Dexcom

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.6645051194539247,
        "turnoverUsdM": 207.57585,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.DXCM",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 83.2158,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 1,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 5.3,
      "take_profit_price": 92.295,
      "target_multiplier": 1.6,
      "technical_strength": 1.38,
      "take_profit_percent": 5
    },
    "positionPoints": 1.4,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.329010238907849,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 55.5,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 52.5,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 3
  },
  "market": {
    "ma20": 89.89,
    "ma50": 81.2224,
    "close": 87.9,
    "prevClose": 89.71,
    "avgVolume20": 4076910,
    "volumeRatio": 0.58,
    "changePercent": -2.02
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 3,
    "details": {
      "ret_5d": -0.03215150847830861,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 3,
      "vcp_bonus": 0,
      "vol_ratio": 0.5635849876137791,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.5713683584291296,
      "volat_points": 0,
      "day_range_pct": 0.015358361774743961,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 55.5,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 4.6,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 92,
        "contribution": 4.6
      },
      {
        "raw": 9.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 46,
        "contribution": 9.2
      },
      {
        "raw": 7.8,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 52,
        "contribution": 7.8
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.6,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 66,
        "contribution": 6.6
      },
      {
        "raw": 18.3,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 61,
        "contribution": 18.3
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "避免",
    "result": 52.5,
    "details": [
      "基本面分析總分: 4.6/5分",
      "資金流分析總分: 9.2/20分",
      "市場環境分析總分: 7.8/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.6/10分",
      "技術信號分析總分: 18.3/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 4.6,
      "資金流": 9.2,
      "市場環境": 7.8,
      "情緒分析": 4,
      "技術信號": 18.3,
      "風險管理": 6.6
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "優秀",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0.75,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0.6,
          "turnoverUsdM": 207.57585,
          "volumePoints": 0.5,
          "revenuePoints": 0.6,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 3.2,
          "obvPoints": 1.6,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.DXCM",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 4,
            "details": {
              "qqq": {
                "ma20": 717.5105010500001,
                "ma50": 711.0850000400001,
                "name": "QQQ",
                "close": 718.96002,
                "points": 2
              },
              "spy": {
                "ma20": 769.0529934000002,
                "ma50": 756.85720062,
                "name": "SPY",
                "close": 770.19,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.6645051194539247,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 0,
          "marketTrendPoints": 4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141425987,
                "url": "https://finnhub.io/api/news?id=fc4b38d168fa041f4c4b91cf02111340a73d4f69976f0c9543c6bcb7f7a9bfbc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom stock has delivered a mixed ride for long term holders, with the share price down about 35.1% over five years even as a Discounted Cash Flow (DCF) estimate points to an intrinsic value that sits meaningfully above the current market price. At the same time, broader valuation checks lean cautious and market based multiples look roughly in line with peers rather than clearly cheap. Over the past five years, DexCom shareholders have seen the stock decline about 35.1%, which puts more...",
                "category": "company",
                "datetime": 1788506376,
                "headline": "DexCom (DXCM) Stock Looks Undervalued On Fair Value While Earnings Look Fair"
              },
              {
                "id": 141403938,
                "url": "https://finnhub.io/api/news?id=9cbd77af170c95d6ccc8f28fb46ec6d763f649ea850e92a5fadc0fb495458a36",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including DexCom (NASDAQ:DXCM) and its peers.",
                "category": "company",
                "datetime": 1788463638,
                "headline": "Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks"
              },
              {
                "id": 141364461,
                "url": "https://finnhub.io/api/news?id=5924938bd1af69a2da1decba43d47368d52414a0182e98dcbb82df881d97656f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Over the past six months, DexCom has been a great trade, beating the S&P 500 by 11.5%. Its stock price has climbed to $91.17, representing a healthy 23.6% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1788275900,
                "headline": "3 Reasons DXCM Has Explosive Upside Potential"
              },
              {
                "id": 141329259,
                "url": "https://finnhub.io/api/news?id=30fc1b6357c6f2bc8fc26f712b11c5d05fc571cd1fc2a9682680b6e7df422e18",
                "image": "https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp",
                "source": "ChartMill",
                "related": "DXCM",
                "summary": "Discover why DexCom (DXCM) fits the Affordable Growth screen, balancing strong earnings growth with reasonable valuation and solid financial health.",
                "category": "company",
                "datetime": 1787829714,
                "headline": "DexCom (NASDAQ:DXCM): An Affordable Growth Play With Strong Momentum and Fair Valuation"
              },
              {
                "id": 141260897,
                "url": "https://finnhub.io/api/news?id=1aa748c6454c5709667df847e2b041609d81fa06ac39eba29d031974cbb6a7e8",
                "image": "https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp",
                "source": "ChartMill",
                "related": "DXCM",
                "summary": "Dexcom (DXCM) passes strong growth & technical screens with high scores, solid fundamentals, and a bull flag breakout setup.",
                "category": "company",
                "datetime": 1787225475,
                "headline": "Dexcom (NASDAQ:DXCM) Combines Strong Growth With a Bullish Technical Setup"
              },
              {
                "id": 141282900,
                "url": "https://finnhub.io/api/news?id=b47dcd551d0c8237a94eb4f8c6223856397daabc1debc0d4516c4a0d178c1358",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom stock has gained 33.4% year to date, yet the valuation picture is mixed, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to meaningful upside while the broader checks lean less generous. For investors, the question is how to weigh a DCF signal that suggests the shares trade at a discount against a low overall value score. Year to date, DexCom is up 33.4%, which puts more pressure on the current price to be supported by future cash flows. Expectations...",
                "category": "company",
                "datetime": 1787018909,
                "headline": "DexCom (DXCM) Stock May Trade At A 37% Discount On Cash Flow"
              },
              {
                "id": 141239209,
                "url": "https://finnhub.io/api/news?id=f5e5a944e5b5fed36bd36d7275c18b31dc508df8f25d7b98535c11f42c129b4a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom stock reacts to recent performance and fundamentals DexCom (DXCM) has attracted investor attention after a recent share price move, with the stock closing at US$89.75. The company’s returns over the past month and past 3 months now stand out against its longer term record. See our latest analysis for DexCom. Short term momentum in DexCom has been strong, with the 30 day share price return of 17.09% and the 90 day share price return of 34.06% contrasting with a more modest 1 year total...",
                "category": "company",
                "datetime": 1786979791,
                "headline": "DexCom (DXCM) Rebounds On Growth Hopes, Does It Look Fully Valued?"
              },
              {
                "id": 141239210,
                "url": "https://finnhub.io/api/news?id=68527f962f1107807a5e0264b10d46c55183f0f056fcdb7ce561c4c366a7af80",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom’s latest analyst work shows a modest lift in the modelled fair value, with the price target figure moving from US$91.64 to US$94.12. This adjustment sits alongside mixed analyst commentary that balances positive Q2 2026 execution, new clinical data and guidance updates, and ongoing questions about valuation and sector sentiment. As you read on, you will see how these moving parts shape the current story around DexCom and how to keep track of future shifts in the narrative. Stay updated...",
                "category": "company",
                "datetime": 1786954179,
                "headline": "DexCom (DXCM) Stock Sees Modest Fair Value Lift After Q2 And Clinical Updates"
              }
            ],
            "raw_source": [
              {
                "id": 141425987,
                "url": "https://finnhub.io/api/news?id=fc4b38d168fa041f4c4b91cf02111340a73d4f69976f0c9543c6bcb7f7a9bfbc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom stock has delivered a mixed ride for long term holders, with the share price down about 35.1% over five years even as a Discounted Cash Flow (DCF) estimate points to an intrinsic value that sits meaningfully above the current market price. At the same time, broader valuation checks lean cautious and market based multiples look roughly in line with peers rather than clearly cheap. Over the past five years, DexCom shareholders have seen the stock decline about 35.1%, which puts more...",
                "category": "company",
                "datetime": 1788506376,
                "headline": "DexCom (DXCM) Stock Looks Undervalued On Fair Value While Earnings Look Fair"
              },
              {
                "id": 141403938,
                "url": "https://finnhub.io/api/news?id=9cbd77af170c95d6ccc8f28fb46ec6d763f649ea850e92a5fadc0fb495458a36",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Wrapping up Q2 earnings, we look at the numbers and key takeaways for the patient monitoring stocks, including DexCom (NASDAQ:DXCM) and its peers.",
                "category": "company",
                "datetime": 1788463638,
                "headline": "Q2 Earnings Highs And Lows: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks"
              },
              {
                "id": 141396046,
                "url": "https://finnhub.io/api/news?id=90fc089244dc8485ed1bae6ed814953047aba3ac1c4095ec57995ccba0e89f82",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Reviewing prior stock picks is how investors turn experience into valuable feedback.  A recommendation is only a thesis until the market tests it.  Watch Doug discuss recent stock picks, provide input on the current market environment—and take your questions.",
                "category": "company",
                "datetime": 1788414660,
                "headline": "Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services"
              },
              {
                "id": 141364461,
                "url": "https://finnhub.io/api/news?id=5924938bd1af69a2da1decba43d47368d52414a0182e98dcbb82df881d97656f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Over the past six months, DexCom has been a great trade, beating the S&P 500 by 11.5%. Its stock price has climbed to $91.17, representing a healthy 23.6% increase. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.",
                "category": "company",
                "datetime": 1788275900,
                "headline": "3 Reasons DXCM Has Explosive Upside Potential"
              },
              {
                "id": 141364462,
                "url": "https://finnhub.io/api/news?id=13c97255d370689eb9f90297a0211b08089b8745c33c05d2de88651317780fa0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "SAN DIEGO, September 01, 2026--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026.",
                "category": "company",
                "datetime": 1788269400,
                "headline": "Dexcom Announces Upcoming Conference Presentation"
              },
              {
                "id": 141364463,
                "url": "https://finnhub.io/api/news?id=c9b6fc6bffb3e3d7e0e29642779ed31313c55591b3bc61dab67540e17181933a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",
                "category": "company",
                "datetime": 1788183001,
                "headline": "Here's How Much a $1000 Investment in DexCom Made 10 Years Ago Would Be Worth Today"
              },
              {
                "id": 141352563,
                "url": "https://finnhub.io/api/news?id=62cc47117b3b9089b94543a3b43428caf46231c1d5d9006a1fe7d5275c3d64c8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Great stock picks are just the start to building a portfolio that can shelter you through whatever the market brings.",
                "category": "company",
                "datetime": 1788100202,
                "headline": "Everything I Learned from My Hot Chart Summer, and How My 21 Stocks Picks Have Performed."
              },
              {
                "id": 141361642,
                "url": "https://finnhub.io/api/news?id=2d68e10e6a7fe49f93f31c64a7e7e06caaf9f1daf2c0dc4f723072ce37ddb7f2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Abbott just scored a regulatory first in diabetes care that no rival has matched, yet the stock sits well below where it traded a year ago. The real question is what it will actually take to close that gap.",
                "category": "company",
                "datetime": 1787861759,
                "headline": "The FDA Just Gave Abbott a Diabetes First. Is Its Beaten-Down Stock Ready to Wake Up?"
              },
              {
                "id": 141329259,
                "url": "https://finnhub.io/api/news?id=30fc1b6357c6f2bc8fc26f712b11c5d05fc571cd1fc2a9682680b6e7df422e18",
                "image": "https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp",
                "source": "ChartMill",
                "related": "DXCM",
                "summary": "Discover why DexCom (DXCM) fits the Affordable Growth screen, balancing strong earnings growth with reasonable valuation and solid financial health.",
                "category": "company",
                "datetime": 1787829714,
                "headline": "DexCom (NASDAQ:DXCM): An Affordable Growth Play With Strong Momentum and Fair Valuation"
              },
              {
                "id": 141361644,
                "url": "https://finnhub.io/api/news?id=ac13f57821e8edb85d717370a97036cf679147e1084cd7f872b6af7481c57b7b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Dexcom CEO Jake Leach said he is watching for a decision by the federal health insurance program before the end of the year.",
                "category": "company",
                "datetime": 1787828940,
                "headline": "Dexcom, Abbott await Medicare coverage expansion for CGMs"
              },
              {
                "id": 141323906,
                "url": "https://finnhub.io/api/news?id=d51cae098bce93cf8ef7e16d66ce95996ebfd0ed923bffa3c37acb05dd0b23af",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/26/Abbott-Laboratories.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "DXCM",
                "summary": "The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.",
                "category": "company",
                "datetime": 1787736992,
                "headline": "FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking"
              },
              {
                "id": 141364465,
                "url": "https://finnhub.io/api/news?id=51438755ae79e1fd4c7678dd81bbf96f6a8b8b900a62658aeb72f370bcfe0a48",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "ABT edges DXCM on price-target upside and valuation, while both pursue CGM growth through innovation, adoption and strong liquidity.",
                "category": "company",
                "datetime": 1787671440,
                "headline": "Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now?"
              },
              {
                "id": 141364468,
                "url": "https://finnhub.io/api/news?id=f5f23b1f38e5783222ccb643de6fbd02540422cf97dae9f0047cc2cd7a0d4460",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Insulet's Q2 beat and stronger margins contrast with a 2026 growth reset, putting U.S. Type 2 retention at the center of its outlook.",
                "category": "company",
                "datetime": 1787668380,
                "headline": "Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat?"
              },
              {
                "id": 141364467,
                "url": "https://finnhub.io/api/news?id=4e934f90b7cbf82177951e0319e55111a0b294d452106cc79bb6226e88699eb9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "We all knew it was coming. The expected valuation may surprise, though.",
                "category": "company",
                "datetime": 1787616344,
                "headline": "Oura is reportedly eyeing a September IPO that could value it at more than $16B"
              },
              {
                "id": 141314075,
                "url": "https://finnhub.io/api/news?id=cffee9de1f9c3c33dbc7f50b1cfc92908d0a7791b14fc63ba2cec5a04d3d6cb8",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1285071364/image_1285071364.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "DXCM",
                "summary": "Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.",
                "category": "company",
                "datetime": 1787613074,
                "headline": "The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products"
              },
              {
                "id": 141282908,
                "url": "https://finnhub.io/api/news?id=6429838e1ba1dc03a9ed04ac36e53d8e4acf48b97718aa14ff60f8afb6a010bc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 27.5% gain over the past six months, beating the S&P 500 by 16.2 percentage points.",
                "category": "company",
                "datetime": 1787230035,
                "headline": "1 Healthcare Stock to Target This Week and 2 Facing Headwinds"
              },
              {
                "id": 141260897,
                "url": "https://finnhub.io/api/news?id=1aa748c6454c5709667df847e2b041609d81fa06ac39eba29d031974cbb6a7e8",
                "image": "https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp",
                "source": "ChartMill",
                "related": "DXCM",
                "summary": "Dexcom (DXCM) passes strong growth & technical screens with high scores, solid fundamentals, and a bull flag breakout setup.",
                "category": "company",
                "datetime": 1787225475,
                "headline": "Dexcom (NASDAQ:DXCM) Combines Strong Growth With a Bullish Technical Setup"
              },
              {
                "id": 141282177,
                "url": "https://finnhub.io/api/news?id=a860f44797bb4049afb87026628b9e4e61e6e69b9c0bda9d5d99d27a9e72bca4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "IDEXX pairs resilient diagnostics growth, margin gains and expanding innovation with a premium valuation that supports a hold-or-wait stance.",
                "category": "company",
                "datetime": 1787152080,
                "headline": "Is IDXX Worth Buying as Growth Strength Meets a Premium Valuation?"
              },
              {
                "id": 141282900,
                "url": "https://finnhub.io/api/news?id=b47dcd551d0c8237a94eb4f8c6223856397daabc1debc0d4516c4a0d178c1358",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom stock has gained 33.4% year to date, yet the valuation picture is mixed, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to meaningful upside while the broader checks lean less generous. For investors, the question is how to weigh a DCF signal that suggests the shares trade at a discount against a low overall value score. Year to date, DexCom is up 33.4%, which puts more pressure on the current price to be supported by future cash flows. Expectations...",
                "category": "company",
                "datetime": 1787018909,
                "headline": "DexCom (DXCM) Stock May Trade At A 37% Discount On Cash Flow"
              },
              {
                "id": 141239209,
                "url": "https://finnhub.io/api/news?id=f5e5a944e5b5fed36bd36d7275c18b31dc508df8f25d7b98535c11f42c129b4a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom stock reacts to recent performance and fundamentals DexCom (DXCM) has attracted investor attention after a recent share price move, with the stock closing at US$89.75. The company’s returns over the past month and past 3 months now stand out against its longer term record. See our latest analysis for DexCom. Short term momentum in DexCom has been strong, with the 30 day share price return of 17.09% and the 90 day share price return of 34.06% contrasting with a more modest 1 year total...",
                "category": "company",
                "datetime": 1786979791,
                "headline": "DexCom (DXCM) Rebounds On Growth Hopes, Does It Look Fully Valued?"
              },
              {
                "id": 141239210,
                "url": "https://finnhub.io/api/news?id=68527f962f1107807a5e0264b10d46c55183f0f056fcdb7ce561c4c366a7af80",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom’s latest analyst work shows a modest lift in the modelled fair value, with the price target figure moving from US$91.64 to US$94.12. This adjustment sits alongside mixed analyst commentary that balances positive Q2 2026 execution, new clinical data and guidance updates, and ongoing questions about valuation and sector sentiment. As you read on, you will see how these moving parts shape the current story around DexCom and how to keep track of future shifts in the narrative. Stay updated...",
                "category": "company",
                "datetime": 1786954179,
                "headline": "DexCom (DXCM) Stock Sees Modest Fair Value Lift After Q2 And Clinical Updates"
              },
              {
                "id": 141239218,
                "url": "https://finnhub.io/api/news?id=077a2168cb5deaf5ca80958613058d53cd7ad99720e03bea563673a239bb5a37",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage have propelled their returns.",
                "category": "company",
                "datetime": 1786876620,
                "headline": "1 Surging  Stock Worth Your Attention and 2 We Question"
              },
              {
                "id": 141239219,
                "url": "https://finnhub.io/api/news?id=d502b3aca9770cb7d0c852bc0f297e0002742e19fa3826c412114da27e1908dc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.",
                "category": "company",
                "datetime": 1786837740,
                "headline": "1 Growth Stock to Stash and 2 We Brush Off"
              },
              {
                "id": 141222074,
                "url": "https://finnhub.io/api/news?id=6fe27bc47a7e8347028dcdda4d8cb3921670a4289105803826933cdfebbd53c3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.",
                "category": "company",
                "datetime": 1786741260,
                "headline": "1 S&P 500 Stock on Our Buy List and 2 We Avoid"
              },
              {
                "id": 141239211,
                "url": "https://finnhub.io/api/news?id=b289ca727cd89f3c379346cada98bade879e9d321ebea35fa79f7e447fc37245",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Despite DexCom’s weak performance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.",
                "category": "company",
                "datetime": 1786725722,
                "headline": "Is Wall Street Bullish or Bearish on DexCom Stock?"
              },
              {
                "id": 141205706,
                "url": "https://finnhub.io/api/news?id=430497268c70129a4879853cd33c768164966340abd44b341d4405ce90b19c04",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",
                "category": "company",
                "datetime": 1786624202,
                "headline": "Here's How Much You'd Have If You Invested $1000 in DexCom a Decade Ago"
              },
              {
                "id": 141201019,
                "url": "https://finnhub.io/api/news?id=1aa92c0aab20c444ee84793b2caf7aaf30fc6c99216a92f3f0268486f4eedfa5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom's broader CGM coverage, G7 15 Day rollout and rising margins support growth, but premium valuation, competition and litigation temper upside.",
                "category": "company",
                "datetime": 1786559760,
                "headline": "Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?"
              },
              {
                "id": 141201020,
                "url": "https://finnhub.io/api/news?id=ddfda041743b4f24e2d48daf51cce1bb0484ffd7706c999a89017cb4fa9463d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DXCM's 2026 rebound is backed by stronger growth, G7 15 Day adoption and broader CGM access, but competition and reimbursement remain key risks.",
                "category": "company",
                "datetime": 1786559640,
                "headline": "DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?"
              },
              {
                "id": 141201022,
                "url": "https://finnhub.io/api/news?id=9062547e50b2e139dce3b7f0cffcbcf26cab494e9078fcdbe88c1dc36acc6671",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom's 52.5% three-month rally is backed by earnings growth and margin gains, but premium valuation, competition and litigation raise the bar.",
                "category": "company",
                "datetime": 1786559580,
                "headline": "DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?"
              },
              {
                "id": 141201021,
                "url": "https://finnhub.io/api/news?id=bc53f2380d39af62eb4e5d935c4911c9a57207ef6b15ff7a3d34ff4ac34dcdfe",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "DXCM",
                "summary": "DexCom raises its 2026 revenue and margin outlook as G7 15 Day efficiencies lift profitability, while FX and transition costs remain key tests.",
                "category": "company",
                "datetime": 1786559580,
                "headline": "Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 30,
            "discarded_article_count": 19
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.3,
        "grade": "一般",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 3,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 3,
            "vcp_reason": "波幅收縮(25.9%→5.8%)；量縮(v10/v30=0.63)；跌縮量(近10日5日)；站上MA50；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 4828803.333333333,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 3018050,
              "avg_vol_20": 4190140,
              "avg_vol_30": 4828803.333333333,
              "range_pct_10": 0.057792946530147875,
              "range_pct_20": 0.11945397042093292,
              "range_pct_30": 0.2593856655290102,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 0,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.6250099230934373,
              "dist_to_20d_high": 0.05065341829571225,
              "down_shrink_days": 5,
              "breakout_level_20d": 92.59,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.2228070175438596
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 1,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.6645051194539247,
              "turnoverUsdM": 207.57585,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.DXCM",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 83.2158,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 1,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 5.3,
            "take_profit_price": 92.295,
            "target_multiplier": 1.6,
            "technical_strength": 1.38,
            "take_profit_percent": 5
          },
          "positionPoints": 1.4,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.329010238907849,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.DXCM",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 2.3421,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.66
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -126.55
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0751
    },
    "kdj": {
      "d": 46.84,
      "j": 11.79,
      "k": 35.16,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 61.94
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 51081900,
      "recentSlope": -410980,
      "previousSlope": 2437810
    },
    "rsi": 46.49,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 91.9201,
      "position": "SAR喺價上",
      "distancePct": 4.57,
      "previousTrend": "下降"
    },
    "ma50": 81.2224,
    "macd": {
      "macd": 2.158029899320624,
      "trend": "中性偏多",
      "signal": 2.891020405982362,
      "histogram": -0.7329905066617379
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 89.7168,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.58,
      "score": 2,
      "avgVolume": 4076910,
      "currentVolume": 2361500
    },
    "derived": {
      "ma20": 89.89,
      "ma50": 81.2224,
      "prevClose": 89.71,
      "avgVolume10": 2906070,
      "avgVolume20": 4076910,
      "changePercent": -2.02,
      "avgVolumeForScore": 4076910
    },
    "ma_cross": {
      "ma20": 89.89,
      "ma50": 81.2224,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 89.7325,
      "prevMa50": 80.8374,
      "spreadPct": 10.67,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 87.6339,
      "upper": 92.1461,
      "position": "中間"
    },
    "rsi_short": 36.02,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.58
    }
  }
}

{
  "close": 87.9,
  "volume": 2361500,
  "changePercent": -2.02
}